Hawaii gets $688,105 in Pfizer settlement

The multistate case alleged the company promoted its drugs for unapproved uses

By Kristen Consillio

POSTED: 01:30 a.m. HST, Dec 13, 2012

~~<p>The state has ramped up efforts to crack down on pharmaceutical companies for promoting their drugs for uses not approved by the U.S. Food and Drug Administration, resulting in at least four major settlements this year.</p>
<p>The most recent case announced Wednesday resulted in a $42.9 million multistate settlement with drug maker Pfizer Inc. involving Hawaii and 31 other states and Washington, D.C. Hawaii's share of the settlement was $688,105, according to the state Department of Commerce & Consumer Affairs Office of Consumer Protection.</p>
<table width="180" height="238" align="right" class="infoboxright_table">
<tbody>
<tr>
<td>
~~

The state has ramped up efforts to crack down on pharmaceutical companies for promoting their drugs for uses not approved by the U.S. Food and Drug Administration, resulting in at least four major settlements this year.

The most recent case announced Wednesday resulted in a $42.9 million multistate settlement with drug maker Pfizer Inc. involving Hawaii and 31 other states and Washington, D.C. Hawaii's share of the settlement was $688,105, according to the state Department of Commerce & Consumer Affairs Office of Consumer Protection. Login for more...